These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21719116)

  • 1. Use of recombinant interferon omega in feline retrovirosis: from theory to practice.
    Doménech A; Miró G; Collado VM; Ballesteros N; Sanjosé L; Escolar E; Martin S; Gomez-Lucia E
    Vet Immunol Immunopathol; 2011 Oct; 143(3-4):301-6. PubMed ID: 21719116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-Up of Viral Parameters in FeLV- or FIV-Naturally Infected Cats Treated Orally with Low Doses of Human Interferon Alpha.
    Gomez-Lucia E; Collado VM; Miró G; Martín S; Benítez L; Doménech A
    Viruses; 2019 Sep; 11(9):. PubMed ID: 31514435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats.
    de Mari K; Maynard L; Sanquer A; Lebreux B; Eun HM
    J Vet Intern Med; 2004; 18(4):477-82. PubMed ID: 15320583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of feline interferon omega for clinical improvement and reduction of concurrent viral excretion in retrovirus infected cats from a rescue shelter.
    Gil S; Leal RO; Duarte A; McGahie D; Sepúlveda N; Siborro I; Cravo J; Cartaxeiro C; Tavares LM
    Res Vet Sci; 2013 Jun; 94(3):753-63. PubMed ID: 23122808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of two virustatica (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms.
    Hartmann K; Donath A; Beer B; Egberink HF; Horzinek MC; Lutz H; Hoffmann-Fezer G; Thum I; Thefeld S
    Vet Immunol Immunopathol; 1992 Dec; 35(1-2):167-75. PubMed ID: 1363008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of viremia, proviral load and cytokine profile in naturally feline immunodeficiency virus infected cats treated with two different protocols of recombinant feline interferon omega.
    Leal RO; Gil S; Duarte A; McGahie D; Sepúlveda N; Niza MM; Tavares L
    Res Vet Sci; 2015 Apr; 99():87-95. PubMed ID: 25747956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Recombinant Feline Interferon-Omega as an alternative immune modulation therapy in FIV positive cats: clinical and laboratory evaluation.
    Gil S; Leal RO; McGahie D; Sepúlveda N; Duarte A; Niza MM; Tavares L
    Res Vet Sci; 2014 Feb; 96(1):79-85. PubMed ID: 24332273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feline immunodeficiency virus lacks sensitivity to the antiviral activity of feline IFN-gamma.
    Tanabe T; Yamamoto JK
    J Interferon Cytokine Res; 2001 Dec; 21(12):1039-46. PubMed ID: 11798461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection.
    Hofmann-Lehmann R; Holznagel E; Aubert A; Ossent P; Reinacher M; Lutz H
    Vet Immunol Immunopathol; 1995 May; 46(1-2):127-37. PubMed ID: 7618252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parameters of disease progression in long-term experimental feline retrovirus (feline immunodeficiency virus and feline leukemia virus) infections: hematology, clinical chemistry, and lymphocyte subsets.
    Hofmann-Lehmann R; Holznagel E; Ossent P; Lutz H
    Clin Diagn Lab Immunol; 1997 Jan; 4(1):33-42. PubMed ID: 9008278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of T-cell subpopulations in cats naturally infected with feline leukaemia virus or feline immunodeficiency virus.
    Hoffmann-Fezer G; Mortelbauer W; Hartmann K; Mysliwietz J; Thefeld S; Beer B; Thum I; Kraft W
    Res Vet Sci; 1996 Nov; 61(3):222-6. PubMed ID: 8938851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring acute phase proteins in retrovirus infected cats undergoing feline interferon-ω therapy.
    Leal RO; Gil S; Sepúlveda N; McGahie D; Duarte A; Niza MM; Tavares L
    J Small Anim Pract; 2014 Jan; 55(1):39-45. PubMed ID: 24279640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of feline leukemia virus infection by adoptive transfer of lectin/interleukin-2-activated lymphocytes, interferon-alpha, and zidovudine.
    Zeidner NS; Mathiason-DuBard CK; Hoover EA
    J Immunother Emphasis Tumor Immunol; 1993 Jul; 14(1):22-32. PubMed ID: 8399067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prior Puma Lentivirus Infection Modifies Early Immune Responses and Attenuates Feline Immunodeficiency Virus Infection in Cats.
    Sprague WS; Troyer RM; Zheng X; Wood BA; Macmillian M; Carver S; VandeWoude S
    Viruses; 2018 Apr; 10(4):. PubMed ID: 29677149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited efficacy of topical recombinant feline interferon-omega for treatment of cats with acute upper respiratory viral disease.
    Ballin AC; Schulz B; Helps C; Sauter-Louis C; Mueller RS; Hartmann K
    Vet J; 2014 Dec; 202(3):466-70. PubMed ID: 25457261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-infection with feline retrovirus is related to changes in immunological parameters of cats with sporotrichosis.
    de Miranda LHM; Meli M; Conceição-Silva F; Novacco M; Menezes RC; Pereira SA; Sugiarto S; Dos Reis ÉG; Gremião IDF; Hofmann-Lehmann R
    PLoS One; 2018; 13(11):e0207644. PubMed ID: 30500849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination of cats experimentally infected with feline immunodeficiency virus, using a recombinant feline leukemia virus vaccine.
    Lehmann R; Franchini M; Aubert A; Wolfensberger C; Cronier J; Lutz H
    J Am Vet Med Assoc; 1991 Nov; 199(10):1446-52. PubMed ID: 1666101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 16alpha-Bromo-epiandrosterone therapy modulates experimental feline immunodeficiency virus viremia: initial enhancement leading to long-term suppression.
    Pedersen NC; North TW; Rigg R; Reading C; Higgins J; Leutenegger C; Henderson GL
    Vet Immunol Immunopathol; 2003 Aug; 94(3-4):133-48. PubMed ID: 12909410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Use of Recombinant Feline Interferon Omega Therapy as an Immune-Modulator in Cats Naturally Infected with Feline Immunodeficiency Virus: New Perspectives.
    Leal RO; Gil S
    Vet Sci; 2016 Oct; 3(4):. PubMed ID: 29056740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of presymptomatic FeLV-induced immunodeficiency syndrome with AZT in combination with alpha interferon.
    Hoover EA; Zeidner NS; Mullins JI
    Ann N Y Acad Sci; 1990; 616():258-69. PubMed ID: 1964030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.